The historic rise of Viagra has firmly established as a example of pharmaceutical success, yet its future within the broader sector now triggers questions about potential yields . Copycat versions are undercutting patent protection , causing anxieties that supporting companies heavily reliant to Viagra's former position could be a dangerous strateg